Mp18-05 can imaging response following neoadjuvant chemotherapy in upper tract urothelial cancer be a surrogate for pathologic response?

Pathological response following neoadjuvant chemotherapy (NAC) has been shown to be an excellent surrogate for survival in bladder cancer. In upper tract urothelial cancer (UTUC), unlike bladder, preoperative endoscopic and pathologic assessment of response is difficult. The aim of this study is to determine whether imaging response following NAC predicted the final pathologic stage and outcomes following radical nephroureterectomy (NU).
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Bladder Cancer: Upper Tract Transitional Cell Carcinoma I Source Type: research